Abstract Details

Title Drivers of change in Toronto Western Spasmodic Rating Scale (TWSTRS) scores following botulinum toxin treatment: Impact of geographical region

Topic Movement Disorders

Presentation(s) P5 - (-)

Poster/Presentation
Number 042

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Carlo Colosimo, MD (Universita La Sapienza) PRESENTER	No disclosure on file
Vivay Peter Misra, MD	No disclosure on file
P. D. Charles, MD, FAAN (Vanderbilt University Medical Center)	Dr. Charles has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Charles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Newronika. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iota. Dr. Charles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Charles has stock in Arena Therapeutics. The institution of Dr. Charles has received research support from Pharma 2 B. The institution of Dr. Charles has received research support from Intec. The institution of Dr. Charles has received research support from Merz. The institution of Dr. Charles has received research support from Novartis. The institution of Dr. Charles has received research support from Aeon. The institution of Dr. Charles has received research support from Impax.
	No disclosure on file
Pascal Maisonobe	No disclosure on file
Savary Om	No disclosure on file